Related references
Note: Only part of the references are listed.Adiposity and breast, endometrial, and colorectal cancer risk in postmenopausal women: Quantification of the mediating effects of leptin, C-reactive protein, fasting insulin, and estradiol
S. Ghazaleh Dashti et al.
CANCER MEDICINE (2022)
Anthropometric measures and breast cancer risk among Hispanic women in Puerto Rico
F. A. Ramirez-Marrero et al.
CANCER CAUSES & CONTROL (2022)
Associations of body shape index (ABSI) and hip index with liver, metabolic, and inflammatory biomarkers in the UK Biobank cohort
Sofia Christakoudi et al.
SCIENTIFIC REPORTS (2022)
Associations of body shape phenotypes with sex steroids and their binding proteins in the UK Biobank cohort
Sofia Christakoudi et al.
SCIENTIFIC REPORTS (2022)
Weight change in middle adulthood and risk of cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort
Sofia Christakoudi et al.
INTERNATIONAL JOURNAL OF CANCER (2021)
Association of body-shape phenotypes with imaging measures of body composition in the UK Biobank cohort: relevance to colon cancer risk
Sofia Christakoudi et al.
BMC CANCER (2021)
Use of systemic glucocorticoids and risk of breast cancer in a prospective cohort of postmenopausal women
Manon Cairat et al.
BMC MEDICINE (2021)
A Body Shape Index (ABSI), hip index, and risk of cancer in the UK Biobank cohort
Sofia Christakoudi et al.
CANCER MEDICINE (2021)
Insulin resistance and breast cancer incidence and mortality in postmenopausal women in the Women's Health Initiative
Kathy Pan et al.
CANCER (2020)
A Body Shape Index (ABSI) achieves better mortality risk stratification than alternative indices of abdominal obesity: results from a large European cohort
Sofia Christakoudi et al.
SCIENTIFIC REPORTS (2020)
Glucocorticoid receptors are required effectors of TGFβ1-induced p38 MAPK signaling to advanced cancer phenotypes in triple-negative breast cancer
Carlos Perez Kerkvliet et al.
BREAST CANCER RESEARCH (2020)
Inhibition of the PI3K-AKT-mTOR pathway suppresses the adipocyte-mediated proliferation and migration of breast cancer cells
Jae-Yeo Park et al.
JOURNAL OF CANCER (2020)
PI3K inhibitors protect against glucocorticoid-induced skin atrophy
Shivani Agarwal et al.
EBIOMEDICINE (2019)
The glucocorticoid receptor interferes with progesterone receptor-dependent genomic regulation in breast cancer cells
Maria F. Ogara et al.
NUCLEIC ACIDS RESEARCH (2019)
Glucocorticoid receptor modulation decreases ER-positive breast cancer cell proliferation and suppresses wild-type and mutant ER chromatin association
Eva Tonsing-Carter et al.
BREAST CANCER RESEARCH (2019)
Discovery of a Glucocorticoid Receptor (GR) Activity Signature Using Selective GR Antagonism in ER-Negative Breast Cancer
Diana C. West et al.
CLINICAL CANCER RESEARCH (2018)
The association between metabolic health, obesity phenotype and the risk of breast cancer
Yong-Moon Mark Park et al.
INTERNATIONAL JOURNAL OF CANCER (2017)
Adiposity and cancer at major anatomical sites: umbrella review of the literature
Maria Kyrgiou et al.
BMJ-BRITISH MEDICAL JOURNAL (2017)
Adiposity and cancer at major anatomical sites: umbrella review of the literature
Maria Kyrgiou et al.
BMJ-BRITISH MEDICAL JOURNAL (2017)
Comparison of general obesity and measures of body fat distribution in older adults in relation to cancer risk: meta-analysis of individual participant data of seven prospective cohorts in Europe
Heinz Freisling et al.
BRITISH JOURNAL OF CANCER (2017)
Breast Tumor Kinase (Brk/PTK6) Is Induced by HIF, Glucocorticoid Receptor, and PELP1-Mediated Stress Signaling in Triple-Negative Breast Cancer
Tarah M. Regan Anderson et al.
CANCER RESEARCH (2016)
Interplay of nuclear receptors (ER, PR, and GR) and their steroid hormones in MCF-7 cells
Shubha M. Hegde et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2016)
GR and ER Coactivation Alters the Expression of Differentiation Genes and Associates with Improved ER+ Breast Cancer Outcome
Diana C. West et al.
MOLECULAR CANCER RESEARCH (2016)
Body Fatness and Cancer - Viewpoint of the IARC Working Group
Beatrice Lauby-Secretan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Central obesity and risks of pre- and postmenopausal breast cancer: a dose-response meta-analysis of prospective studies
G. -C. Chen et al.
OBESITY REVIEWS (2016)
An Anthropometric Risk Index Based on Combining Height, Weight, Waist, and Hip Measurements
Nir Y. Krakauer et al.
JOURNAL OF OBESITY (2016)
Clinical and biological significance of glucocorticoid receptor (GR) expression in breast cancer
Rezvan Abduljabbar et al.
BREAST CANCER RESEARCH AND TREATMENT (2015)
Insulin priming effect on estradiol-induced breast cancer metabolism and growth
Peninah M. Wairagu et al.
CANCER BIOLOGY & THERAPY (2015)
Comparison of anthropometric measures as predictors of cancer incidence: A pooled collaborative analysis of 11 Australian cohorts
Jessica L. Harding et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
Form and Function: how Estrogen and Progesterone Regulate the Mammary Epithelial Hierarchy
Lisa M. Arendt et al.
JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA (2015)
Risk of breast, endometrial, colorectal, and renal cancers in postmenopausal women in association with a body shape index and other anthropometric measures
Geoffrey C. Kabat et al.
CANCER CAUSES & CONTROL (2015)
Dexamethasone Disrupts Cytoskeleton Organization and Migration of T47D Human Breast Cancer Cells by Modulating the AKT/mTOR/RhoA Pathway
Xian-Guo Meng et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (2014)
Deconstructing the roles of glucocorticoids in adipose tissue biology and the development of central obesity
Mi-Jeong Lee et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2014)
Estrogen receptor negative/progesterone receptor positive breast cancer is not a reproducible subtype
Marco M. Hefti et al.
BREAST CANCER RESEARCH (2013)
Hip circumference is associated with the risk of premenopausal ER-/PR- breast cancer
G. Fagherazzi et al.
INTERNATIONAL JOURNAL OF OBESITY (2012)
A New Body Shape Index Predicts Mortality Hazard Independently of Body Mass Index
Nir Y. Krakauer et al.
PLOS ONE (2012)
Adiposity, hormone replacement therapy use and breast cancer risk by age and hormone receptor status: a large prospective cohort study
Rebecca Ritte et al.
BREAST CANCER RESEARCH (2012)
Postmenopausal Serum Sex Steroids and Risk of Hormone Receptor-Positive and -Negative Breast Cancer: a Nested Case-Control Study
Rebecca E. James et al.
CANCER PREVENTION RESEARCH (2011)
Body Fat Distribution and Risk of Premenopausal Breast Cancer in the Nurses' Health Study II
Holly R. Harris et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2011)
Molecular profiles of progesterone receptor loss in human breast tumors
Chad J. Creighton et al.
BREAST CANCER RESEARCH AND TREATMENT (2009)
Overweight, obesity and fat distribution in 50-to 64-year-old participants in the European Prospective Investigation into Cancer and Nutrition (EPIC)
M Haftenberger et al.
PUBLIC HEALTH NUTRITION (2002)
Share Paper
